PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical and Clinical Sciences L. Sacco, Università degli Studi di Milano, Milan, Italy.\', \'Luminex B.V., Hertogenbosch, Netherlands.\', \'Division of Infectious Diseases, Aziende Socio Sanitarie Territoriali (ASST) Fatebenefratelli Sacco Hospital, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.793191
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34975897
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all